It makes sense and dollars to buy Companhia Brasileira de Distribuicao (CBD) stock

Companhia Brasileira de Distribuicao (NYSE: CBD) stock jumped 2.38% on Friday to $3.01 against a previous-day closing price of $2.94. With 1.15 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.05 million shares. During the session, the Department Stores company that operates in wider Consumer Cyclical sector, reached to the highest price of $3.0550 whereas the lowest price it dropped to was $2.9400. The 52-week range on CBD shows that it touched its highest point at $5.93 and its lowest point at $2.73 during that stretch. It currently has a 1-year price target of $5.50. With its current market cap of 820.22 million, CBD has annualized dividend of $0.07 while the current yield stands at 2.36%. Beta for the stock currently stands at 1.22.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CBD was down-trending over the past week, with a drop of -0.99%, but this was down by -2.90% over a month. Three-month performance dropped to -29.38% while six-month performance fell -30.03%. The stock lost -48.78% in the past year, while it has lost -23.36% so far this year. A look at the trailing 12-month EPS for CBD yields 0.42 with Next year EPS estimates of 0.32. For the next quarter, that number is -0.02. This implies an EPS growth rate of -26.30% for this year and 220.00% for next year.

Float and Shares Shorts:

At present, 272.50 million CBD shares are outstanding with a float of 159.19 million shares on hand for trading. On Jul 14, 2022, short shares totaled 1.21 million, which was 0.45% higher than short shares on Jun 14, 2022. In addition to Mr. Marcelo Ribeiro Pimentel as the firm’s Chief Exec. Officer, Mr. Guillaume Marie Didier Gras serves as its CFO, Investors Relations Director & Member of Exec. Board.

Institutional Ownership:

Through their ownership of 5.81% of CBD’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 4.34% of CBD, in contrast to 1.07% held by mutual funds. Shares owned by individuals account for –. As the largest shareholder in CBD with 0.80% of the stake, Harding Loevner LP holds 2,163,495 shares worth 2,163,495. A second-largest stockholder of CBD, The Vanguard Group, Inc., holds 969,731 shares, controlling over 0.36% of the firm’s shares. Millennium Management LLC is the third largest shareholder in CBD, holding 887,907 shares or 0.33% stake. With a 0.18% stake in CBD, the Vanguard Total International Stoc is the largest stakeholder. A total of 487,432 shares are owned by the mutual fund manager. The Vanguard Emerging Markets Stock I, which owns about 0.13% of CBD stock, is the second-largest Mutual Fund holder. It holds 354,344 shares valued at 1.1 million. Genesis Emerging Markets Investme holds 0.12% of the stake in CBD, owning 309,177 shares worth 0.96 million.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CBD since 14 analysts follow the stock currently. There are 6 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 8 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With CBD analysts setting a high price target of $9.00 and a low target of $3.46, the average target price over the next 12 months is $5.25. Based on these targets, CBD could surge 199.0% to reach the target high and rise by 14.95% to reach the target low. Reaching the average price target will result in a growth of 74.42% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. CBD will report FY 2022 earnings on 02/22/2023. Analysts have provided yearly estimates in a range of $0.30 being high and -$0.01 being low. For CBD, this leads to a yearly average estimate of $0.11. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Companhia Brasileira de Distribuicao surprised analysts by -$0.08 when it reported -$0.10 EPS against a consensus estimate of -$0.02. The surprise factor in the prior quarter was -$0.04. Based on analyst estimates, the high estimate for the next quarter is $0.00 and the low estimate is -$0.03. The average estimate for the next quarter is thus -$0.01.

Leave a Comment

Your email address will not be published.